NL-OMON34900已完成不适用
Computer supported follow-up after curative treatment of colorectal cancer based on CEA - Intensive CEA measurements in follow-up of colorectal carcinoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •TxNxMo colorectal carcinoma, histologically confirmed
- •operation date 01-01-2007 or later
排除标准
- •fit for metastectomy
研究者
相似试验
尚未招募
不适用
Frequent CEA measurements in follow-up of colorectal carcinoma.follow-upcolorectal cancerCarcinoembryonic AntigenNL-OMON19879niveristy Medical Center Groningen1,800
已完成
1 期
The follow-up of patients after the combination therapy with inactivated nevus and cultured epidermal autograft and the efficacy of the ruby laser irradiation to remove the residual melanin pigmentCongenital melanocytic neviJPRN-UMIN000020908Department of Plastic and Reconstructive Surgery, Kansai Medical University,10
尚未招募
不适用
Towards patient-led follow-up after curative treatment of stage II and III colorectal cancer<p>Colorectal cancer</p>NL-OMON20781/A360
进行中（未招募）
不适用
A Long-Term, Post treatment, Safety Follow-up, Multi-Centre Study in Patients with Type 2 Diabetes Mellitus from the GALLANT, GALLEX or ARMOR Studies, G-PLUS (GALLANT, GALLEX and ARMOR - Post treatment Long-term follow-Up Study) - G-PLUSType II Diabetes MellitusMedDRA version: 7Level: LLTClassification code 10045242EUCTR2005-001373-97-LTAstraZeneca AB4,500
进行中（未招募）
1 期
A Long-Term, Post treatment, Safety Follow-up, Multi-Centre Study in Patients with Type 2 Diabetes Mellitus from the GALLANT, GALLEX or ARMOR Studies, G-PLUS (GALLANT, GALLEX and ARMOR - Post treatment Long-term follow-Up Study) - G-PLUSEUCTR2005-001373-97-GBAstraZeneca AB4,500